CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
Abstract Tumor-infiltrating CD8 + T cells progressively lose functionality and fail to reject tumors. The underlying mechanism and re-programing induced by checkpoint blockers are incompletely understood. We show here that genetic ablation or pharmacological inhibition of histone lysine methyltransf...
Main Authors: | Leticia Laura Niborski, Paul Gueguen, Mengliang Ye, Allan Thiolat, Rodrigo Nalio Ramos, Pamela Caudana, Jordan Denizeau, Ludovic Colombeau, Raphaël Rodriguez, Christel Goudot, Jean-Michel Luccarini, Anne Soudé, Bruno Bournique, Pierre Broqua, Luigia Pace, Sylvain Baulande, Christine Sedlik, Jean-Pierre Quivy, Geneviève Almouzni, José L. Cohen, Elina Zueva, Joshua J. Waterfall, Sebastian Amigorena, Eliane Piaggio |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-31504-z |
Similar Items
-
Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
by: Leticia Laura Niborski, et al.
Published: (2023-05-01) -
The methyltransferase Suv39h1 links the SUMO pathway to HP1α marking at pericentric heterochromatin
by: Christèle Maison, et al.
Published: (2016-07-01) -
CENP-A Regulation and Cancer
by: Charlène Renaud-Pageot, et al.
Published: (2022-06-01) -
Treg-targeted IL-2/anti-IL-2 complex controls graft-<i>versus</i>-host disease and supports anti-tumor effect in allogeneic hematopoietic stem cell transplantation
by: Allan Thiolat, et al.
Published: (2023-09-01) -
Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.
by: Eugeni Entchev, et al.
Published: (2020-01-01)